Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Katherine Smith

Child & Adolescent Psychiatry Shreveport, LA Medical Doctor

NPI 1497998835 CMS profile 1386816

1006 Highland Ave, Shreveport, LA 71101

Open in the dashboard

General payments

$3,381

190 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,514 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Katherine Smith of Shreveport, LA is reported in the CMS Open Payments database as having received $3,381 across 190 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,514 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Child & Adolescent Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $130 6
2024 General $271 14
2023 General $1,095 56
2022 General $957 50
2021 General $572 37
2020 General $183 12
2019 General $172 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Katherine Smith
  • Child & Adolescent Psychiatry median
  • Middle half of Child & Adolescent Psychiatry
  • National median

In program year 2025, general payments to Katherine Smith were reported at $130. Among 1,601 Child & Adolescent Psychiatry profiles paid that year, the median was $132 and the middle half received between $41 and $474.

Show as a table
Year Katherine Smith Child & Adolescent Psychiatry median Middle half National median
2019 $172 $129 $42–$419 $163
2020 $183 $81 $28–$226 $114
2021 $572 $115 $31–$326 $132
2022 $957 $124 $40–$382 $149
2023 $1,095 $130 $45–$420 $160
2024 $271 $141 $42–$490 $164
2025 $130 $132 $41–$474 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Teva Pharmaceuticals USA, Inc. $652 40 payments
  2. ITI, Inc. $503 29 payments
  3. Sunovion Pharmaceuticals Inc. $428 34 payments
  4. Lundbeck LLC $326 17 payments
  5. Alkermes, Inc. $237 13 payments
  6. Otsuka America Pharmaceutical, Inc. $231 14 payments
  7. Corium, Inc. $225 5 payments
  8. Janssen Pharmaceuticals, Inc $200 9 payments
  9. Neurocrine Biosciences, Inc. $195 10 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $110 7 payments
  11. Other $275 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,381 190 payments
Products named General payments · program years 2019–2025
  1. CAPLYTA $503 29 payments
  2. AUSTEDO $502 32 payments
  3. LATUDA $428 34 payments
  4. ABILIFY MAINTENA $241 14 payments
  5. LYBALVI $237 13 payments
  6. ARISTADA Cns $237 13 payments
  7. ARISTADA Cns $237 13 payments
  8. ARISTADA Cns $237 13 payments
  9. ARISTADA Cns $237 13 payments
  10. Azstarys $225 5 payments
  11. Other $1,755 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

190 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Child & Adolescent Psychiatry in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record